Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma (Q39325740)
scientific article published on June 22, 2012
Language:
(P31) (Q13442814)
(P304) 28087-28098
(P407) (Q1860)
(P433) 33
(P478) 287
(P577) Friday, June 22, 2012
(P921) (Q2656896)
(P953) http://www.jbc.org/content/287/33/28087.full.pdf
https://europepmc.org/articles/PMC3431627
https://europepmc.org/articles/PMC3431627?pdf=render
https://doi.org/10.1074/jbc.m112.377218
https://api.elsevier.com/content/article/PII:S0021925820478317?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0021925820478317?httpAccept=text/plain
https://syndication.highwire.org/content/doi/10.1074/jbc.M112.377218
(P1433) (Q867727)
(P1476) "Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma" (language: en)
"Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma" (language: en)
(P2093) Vipin Yadav
Xiaoyi Zhang
Jiangang Liu
Shawn Estrem
Shuyu Li
Xue-Qian Gong
Sean Buchanan
Sheng-Bin Peng
James R. Henry
James J. Starling
(P2860) (Q29620033)
(Q35146471)
(Q24631953)
(Q28235184)
(Q27851628)
(Q37841746)
(Q22241238)
(Q37830845)
(Q29614757)
(Q33770265)
(Q24629474)
(Q29615032)
(Q24597152)
(Q27860458)
(Q24298749)
(Q29614803)
(Q36735178)
(Q34011519)
(Q24652600)
(Q37004743)
(Q29615526)
(Q29614281)
(Q24536351)
(Q24297423)
(Q28251989)
(Q38351528)
(Q34837255)
(Q27860760)
(Q28609620)
(Q39421033)
(Q39477725)
(Q39580861)
(Q39640222)
(Q39971699)
(Q40164535)
(Q40253550)
(Q45345602)
other details
description scientific article published on June 22, 2012

External Links